• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Trump rescinds Biden order protecting gender clinics from investigation, signals new whistleblower protections

by February 24, 2025
written by February 24, 2025

The Trump administration is rescinding a Biden-era directive protecting hospitals from investigations and signaled that beefed-up protections for medical whistleblowers would be forthcoming.

The Health and Human Services Department (HHS) announced Friday it would be rescinding an executive order issued by former President Joe Biden in March 2022, which, among other things, gave hospitals the right not to comply with state-level investigations related to their provision of transgender medical treatments to minors. 
Trump’s directive eliminates these protections, and the rescission notice indicates that further safeguards for medical whistleblowers are anticipated in the future.

‘Under the Biden regime, the door for whistleblowers was closed,’ said Dr. Eithan Haim, who was prosecuted by the Biden administration after he leaked documents to the media that revealed Texas Children’s Hospital in Houston was performing transgender medical procedures on minors, even after it said it had stopped. ‘It was a complete inversion of the role of HHS, the role of our legal framework, because the criminal entities were being protected and the individuals exposing criminal entities were now the ones being targeted.’

Haim was indicted last year by Biden’s Department of Justice for blowing the whistle on Texas Children’s Hospital, after it continued to provide transgender medical treatments to minors even though the hospital had publicly indicated it had stopped such services in order to comply with new state guidance. Several days after President Donald Trump was sworn in, the charges against Haim were dropped. 

Under Biden’s March 2022 directive, titled, ‘HHS Notice and Guidance on Gender Affirming Care, Civil Rights and Patient Privacy,’ hospitals were permitted, but not required, to comply with investigations seeking information on their provision of transgender treatments. But, according to HHS’s rescission notice, such guidance lacked ‘adequate legal basis under federal privacy laws.’ The notice added that, ‘by its own terms,’ Biden’s March 2022 directive ‘permits’ the release of personal health information tied to transgender procedures when it is needed to comply with other laws. 

‘Covered entities should no longer rely on the rescinded 2022 OCR Notice and Guidance,’ stated HHS’ rescission notice. It added that ‘in consultation with the Attorney General’ the agency will also be ‘expeditiously’ issuing new guidance to protect whistleblowers who take action in accordance with Trump’s efforts to protect children ‘from chemical and surgical mutilation.’ 

Haim said that under Trump’s new leadership, the U.S. legal system is being restored ‘to a place of equal protection under law, particularly as it relates to people who are trying to follow [Trump’s] executive order, or any other federal laws.’

‘The key thing with this new directive is that, as a healthcare provider, if a hospital or other doctors are participating in misconduct, if they’re lying about something, if they are intervening on patients in a way that is harmful to those patients – especially kids – as a doctor, it’s not only something you should do, it’s something you have to do,’ Haim pointed out.

In addition to compelling hospitals and gender clinics to begin rigorous compliance with investigations, the Trump administration’s Friday directive also removed gender dysphoria from being considered a disability under the federal Rehabilitation Act and the Americans with Disabilities Act. It also rescinded orders from the Biden administration indicating it was discrimination for federally funded health programs to refuse to treat someone on the basis of their gender identity.

Fox News Digital reached out to HHS for comment but did not receive a response by publication time.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump tax cut plan hits turbulence ahead of House vote as Republicans split
next post
‘Overwhelmingly popular’: Elon Musk touts Americans’ DOGE support

related articles

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

US diplomatic facility in Iraq struck by drone

March 13, 2026

171 million travelers face airport delays as Democrats’...

March 13, 2026

From Biden’s ‘war’ on gas prices to ‘small...

March 13, 2026

FDA launches new AI-powered system to track drug...

March 13, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 13, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 13, 2026

Trump touts 5-0 sweep by endorsed candidates in...

March 13, 2026

US destroys 16 Iranian mine boats as Strait...

March 13, 2026

House GOP urges Trump to choke off Iran...

March 13, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • HomeStreet Bank sells $990M in loans to BofA in strategic profit push

    December 27, 2024
  • Pope Francis-era deal with Chinese Communist Party again under scrutiny as Pope Leo takes the reins

    May 9, 2025
  • Sotomayor breaks with Jackson in Supreme Court decision over Trump cuts to federal workforce

    July 9, 2025
  • Biden still regrets dropping out of 2024 presidential race, believes he could have beaten Trump: report

    December 28, 2024
  • House Speaker Johnson calls Biden’s last-minute pardons ‘shocking’ and ‘disgusting’

    January 22, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025

Categories

  • Economy (829)
  • Editor's Pick (8,376)
  • Investing (1,189)
  • Stock (981)

Latest Posts

  • Delta says chaos after CrowdStrike outage cost it $550 million

    August 9, 2024
  • Trump says first lady ‘hates when I do this’ in public — the moment he can’t help repeating

    January 6, 2026
  • UnitedHealth says it faces DOJ investigation over Medicare billing practices

    July 24, 2025

Recent Posts

  • WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

    September 18, 2025
  • Biden ‘rang the bell’ after completing radiation therapy for prostate cancer

    October 21, 2025
  • Havana Syndrome study halted as review finds some patients were coerced

    September 16, 2024

Editor’s Pick

  • New House Freedom Caucus chair reveals GOP rebel group’s next ‘big fight’

    September 18, 2024
  • Comey expects further legal scrutiny from Trump admin, criticizes ‘fools who would frighten us’

    November 25, 2025
  • ‘DOGE is not dead,’ defiant House caucus leader declares in push to revive Musk-era cuts

    December 8, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock